Tianda Pharmaceuticals Cash Flow Statement

Financials in millions HKD. Fiscal year is January - December.

Millions HKD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2022	FY 2021
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Net Income	-67.37	-61.37	-24.16	-54.64	-19.77	-27.14
Depreciation & Amortization	36.59	36.28	34.47	48.25	20.03	19.28
Other Amortization	1.95	1.95	1.94	2	2.12	1.33
Loss (Gain) From Sale of Assets	0.1	0.1	-0.14	-1.25	-12.03	0.07
Asset Writedown & Restructuring Costs	1.34	1.34	-	-	1.58	-
Loss (Gain) From Sale of Investments	-	-	-	0.12	0.02	0.02
Provision & Write-off of Bad Debts	-0.6	-0.6	0.79	0.62	0.44	-0.05
Other Operating Activities	57.59	-2.16	-4.68	-7.07	-20.04	-8.44
Change in Accounts Receivable	26	26	33.31	-14.63	9.08	-45.1
Change in Inventory	23.5	23.5	-18.9	19.23	-8.68	-11.39
Change in Accounts Payable	4.85	4.85	35.48	-32.97	13.41	55.16
Change in Other Net Operating Assets	-39.6	-39.6	-107.86	142.23	5.62	-21.39
Operating Cash Flow	44.37	-9.7	-49.76	101.9	-8.23	-37.63
Capital Expenditures	-21.25	-20.61	-49.28	-33.28	-53.76	-145.68
Sale of Property, Plant & Equipment	0.09	0.09	0.28	1.63	0.03	0
Divestitures	-	-	-	-	151.9	-
Sale (Purchase) of Intangibles	-9.97	-16.88	-17	-	-	-0.77
Investment in Securities	-11.35	-10.86	-6.14	14.49	-13.77	5.27
Other Investing Activities	15.95	16.48	3.03	4.34	1.95	3.44
Investing Cash Flow	-26.53	-31.78	-69.1	-12.81	86.35	-137.73
Long-Term Debt Issued	-	75.92	43.46	-	33.46	110.61
Total Debt Issued	117.99	75.92	43.46	21.54	33.46	110.61
Long-Term Debt Repaid	-	-100.98	-70.03	-	-25.31	-10.38
Total Debt Repaid	-140.93	-100.98	-70.03	-36.68	-25.31	-10.38
Net Debt Issued (Repaid)	-22.94	-25.06	-26.58	-15.14	8.15	100.22
Common Dividends Paid	-3.17	-5.59	-5.59	-23.5	-8.56	-2.53
Other Financing Activities	-	-	-25.23	0.12	-0.89	-6.94
Financing Cash Flow	-26.11	-30.65	-57.39	-38.52	-1.3	90.75
Foreign Exchange Rate Adjustments	2.14	-4.63	-1.58	-42.21	8.93	20.9
Net Cash Flow	-6.13	-76.75	-177.84	8.37	85.76	-63.72
Free Cash Flow	23.12	-30.3	-99.04	68.63	-61.98	-183.32
Free Cash Flow Margin	7.45%	-9.18%	-18.61%	12.55%	-12.16%	-38.65%
Free Cash Flow Per Share	0.01	-0.01	-0.05	0.03	-0.03	-0.09
Cash Interest Paid	4.85	4.85	4.95	6.72	-	0.57
Cash Income Tax Paid	5.96	5.96	-0.37	0.41	-	3.57
Levered Free Cash Flow	-16.89	-71.25	-112.42	-	101.92	-184.5
Unlevered Free Cash Flow	-14.24	-68.22	-109.33	-	102.37	-184.14
Change in Working Capital	14.76	14.76	-57.97	113.86	19.43	-22.71

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.